Showing results (51-60 of 98) with videos related to
Sort By:
Pageof 10
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 24, 2012
Hemorrhagic shock as the initial manifestation of pheochromocytoma: report of a sequential management strategyPatrick B O'Neal, Francis D Moore, Atul Gawande, et al.Surgery|October 2, 2012
Surgeon beware: many patients referred for parathyroidectomy are misdiagnosed with primary hyperparathyroidismJames C Iannuzzi, Daniel X Choi, Rachel L Farkas, et al.Surgery|December 3, 2014
Risk scoring can predict readmission after endocrine surgeryJames C Iannuzzi, Fergal J Fleming, Kristin N Kelly, et al.The Oncologist|March 1, 2011
Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancerCarmelo Nucera, Matthew A Nehs, Sushruta S Nagarkatti, et al.Thyroid : Official Journal of the American Thyroid Association|November 4, 2020
Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and OutcomeKristine S Wong, Fei Dong, Milhan Telatar, et al.Thyroid : Official Journal of the American Thyroid Association|January 25, 2011
Metastatic papillary thyroid cancer misdiagnosed as non-small [corrected] cell lung cancerJacob Moalem, Daniel X Choi, Elham Khanafshar, et al.Thyroid : Official Journal of the American Thyroid Association|May 18, 2010
Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutationNancy L Cho, Chi-Iou Lin, Edward E Whang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2021
Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAF -Driven Papillary Thyroid Cancer PatientsTheodora Pappa, Sara Ahmadi, Ellen Marqusee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2023
Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic OutcomesAthanasios Bikas, Sara Ahmadi, Theodora Pappa, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 13, 2010
Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experienceHiromichi Ito, Michael Abramson, Kaori Ito, et al.Pageof 10